EcoDrugPlus

Neuropeptide Y Receptor Y5

Ensembl ID : ENSCAFG00020005363
Gene Symbol: NPY5R
3 Cross references
137 Possible Orthologues:

Neuropeptide Y Receptor Type 4

Ensembl ID : ENSCAFG00020012316
Gene Symbol: LOC112651731
2 Cross references
116 Possible Orthologues:

Neurotensin Receptor 1

Ensembl ID : ENSCAFG00020001009
Gene Symbol: NTSR1
3 Cross references
208 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 1

Ensembl ID : ENSCAFG00020005056
Gene Symbol: NTRK1
3 Cross references
200 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 2

Ensembl ID : ENSCAFG00020023722
Gene Symbol: NTRK2
3 Cross references
288 Possible Orthologues:

Neurotrophic Receptor Tyrosine Kinase 3

Ensembl ID : ENSCAFG00020018900
Gene Symbol: NTRK3
3 Cross references
271 Possible Orthologues:

Nicastrin

Ensembl ID : ENSCAFG00020020039
Gene Symbol: NCSTN
3 Cross references
204 Possible Orthologues:

Nicotinamide Phosphoribosyltransferase

Ensembl ID : ENSCAFG00020023094
Gene Symbol: NAMPT
3 Cross references
235 Possible Orthologues:

Nischarin

Ensembl ID : ENSCAFG00020000534
Gene Symbol: NISCH
3 Cross references
207 Possible Orthologues:

Nitric Oxide Synthase 2

Ensembl ID : ENSCAFG00020012111
Gene Symbol: NOS2
3 Cross references
166 Possible Orthologues:

Notch Receptor 1

Ensembl ID : ENSCAFG00020002327
Gene Symbol: NOTCH1
3 Cross references
269 Possible Orthologues:

Notch Receptor 3

Ensembl ID : ENSCAFG00020008048
Gene Symbol: NOTCH3
3 Cross references
201 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).